Association Between COPD Exacerbations and Vitamin D Levels

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Milo A. Puhan, MD, PhD; David M. Mannino, MD, FCCP; and CHEST podcast editor D. Kyle Hogarth, MD, FCCP, discuss Dr. Puhan’s study of COPD exacerbations and vitamin D levels.

To listen to this podcast, click here.
Related Articles
The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.
Clostridium difficile-associated diarrhea (CDAD) is an increasingly common cause of inpatient mortality, and recurrent CDAD remains clinically challenging.
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about what the teach-back method is and the pharmacist's role in patient counseling.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$